General Information of This Metabolic Reaction (MR) (ID:
MR000656) |
Formula |
|
Reactant |
OPC-13213 |
Product |
OPC-13213 |
Reactant Info
|
Product Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography J Pharm Biomed Anal. 2001 Jan;24(3):381-9. doi: 10.1016/s0731-7085(00)00426-x.
|
2 |
Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol Drug Metab Dispos. 2007 Oct;35(10):1730-2. doi: 10.1124/dmd.107.016758.
|
3 |
Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites Eur J Clin Pharmacol. 2018 Nov;74(11):1417-1426. doi: 10.1007/s00228-018-2522-5.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.